Intuitive Surgical, Inc. $ISRG Shares Sold by Foundations Investment Advisors LLC

Foundations Investment Advisors LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 93.3% during the third quarter, Holdings Channel reports. The fund owned 2,715 shares of the medical equipment provider’s stock after selling 37,895 shares during the quarter. Foundations Investment Advisors LLC’s holdings in Intuitive Surgical were worth $1,214,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Tobam raised its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $27,000. Princeton Global Asset Management LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at $30,000. Riggs Asset Managment Co. Inc. lifted its stake in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares during the period. Finally, First Command Advisory Services Inc. lifted its stake in shares of Intuitive Surgical by 3,750.0% during the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock worth $42,000 after purchasing an additional 75 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on ISRG. Wells Fargo & Company upped their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Leerink Partners upped their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Evercore ISI cut their price objective on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Sanford C. Bernstein boosted their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Finally, BTIG Research reaffirmed a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $620.41.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 2,067 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the completion of the transaction, the vice president owned 473 shares in the company, valued at $260,150. This represents a 81.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 4,500 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $496,455.52. This trade represents a 83.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 75,683 shares of company stock valued at $42,066,425 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.7%

ISRG opened at $504.22 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $609.08. The company has a 50 day moving average of $558.64 and a two-hundred day moving average of $511.63. The company has a market cap of $180.75 billion, a P/E ratio of 63.91, a P/E/G ratio of 3.92 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the previous year, the business posted $2.21 EPS. The business’s quarterly revenue was up 18.8% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen upgraded ISRG and said the company’s long‑run growth is likely underestimated, supporting a higher multi‑year earnings outlook and raising optimism among growth investors. Intuitive Surgical Inc.’s (ISRG) long-run growth underestimated, says TD Cowen
• Positive Sentiment: Q4/earnings-call takeaways: analysts pressed management on growth drivers and margin outlook, but the quarter showed solid revenue and EPS beats that underpin the company’s recurring parts & services revenue model. That confirms continued demand for da Vinci systems and supports forward estimates. 5 Revealing Analyst Questions From Intuitive Surgical’s Q4 Earnings Call
• Positive Sentiment: Regulatory/product progress: coverage of cardiac clearance work and the rollout of the da Vinci 5 platform suggests new procedure types and market expansion that could lift system sales and higher‑margin consumables over time. Intuitive Surgical’s Cardiac Clearance Tests Valuation As da Vinci 5 Expands
• Positive Sentiment: Analyst/bull commentary: sector bulls and outlets (e.g., Zacks) remain positive on the da Vinci franchise and recurring revenue stream, reinforcing investor conviction on long‑term durability. Bull of the Day: Intuitive Surgical (ISRG)
• Neutral Sentiment: Valuation debate persists: retail analyst pieces note 2025 results were strong but warn the stock’s premium valuation is the main risk — strong fundamentals vs. expensive multiples keeps investor views mixed. Should You Buy Shares of Intuitive Surgical In February?
• Negative Sentiment: Insider selling: EVP Myriam Curet sold small blocks of ISRG shares in recent transactions (e.g., 126 shares at ~$520). The amounts are modest but such filings can create short‑term selling pressure or signal personal diversification. Intuitive Surgical (NASDAQ:ISRG) EVP Myriam Curet Sells 126 Shares

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.